285 related articles for article (PubMed ID: 18290729)
21. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
22. A genomic perspective on vitamin D signaling.
Carlberg C; Seuter S
Anticancer Res; 2009 Sep; 29(9):3485-93. PubMed ID: 19667142
[TBL] [Abstract][Full Text] [Related]
23. The TGFbeta/Smad 3-signaling pathway is involved in butyrate-mediated vitamin D receptor (VDR)-expression.
Daniel C; Schroder O; Zahn N; Gaschott T; Steinhilber D; Stein JM
J Cell Biochem; 2007 Dec; 102(6):1420-31. PubMed ID: 17471513
[TBL] [Abstract][Full Text] [Related]
24. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D regulates the phenotype of human breast cancer cells.
Pendás-Franco N; González-Sancho JM; Suárez Y; Aguilera O; Steinmeyer A; Gamallo C; Berciano MT; Lafarga M; Muñoz A
Differentiation; 2007 Mar; 75(3):193-207. PubMed ID: 17288543
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
[TBL] [Abstract][Full Text] [Related]
28. Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells.
Valrance ME; Brunet AH; Acosta A; Welsh J
J Cell Biochem; 2007 Aug; 101(6):1505-19. PubMed ID: 17286279
[TBL] [Abstract][Full Text] [Related]
29. Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway.
Kemmis CM; Welsh J
J Cell Biochem; 2008 Nov; 105(4):980-8. PubMed ID: 18767073
[TBL] [Abstract][Full Text] [Related]
30. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
Zinser GM; McEleney K; Welsh J
Mol Cell Endocrinol; 2003 Feb; 200(1-2):67-80. PubMed ID: 12644300
[TBL] [Abstract][Full Text] [Related]
31. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.
Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA
Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer survivors and vitamin D: a review.
Hines SL; Jorn HK; Thompson KM; Larson JM
Nutrition; 2010 Mar; 26(3):255-62. PubMed ID: 20004077
[TBL] [Abstract][Full Text] [Related]
33. Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice.
Zinser GM; Welsh J
Mol Endocrinol; 2004 Sep; 18(9):2208-23. PubMed ID: 15178742
[TBL] [Abstract][Full Text] [Related]
34. Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells.
Matthews D; LaPorta E; Zinser GM; Narvaez CJ; Welsh J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):362-7. PubMed ID: 20412854
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo.
Valrance ME; Brunet AH; Welsh J
Endocrinology; 2007 Oct; 148(10):4887-94. PubMed ID: 17628009
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D-3 receptor as a target for breast cancer prevention.
Welsh J; Wietzke JA; Zinser GM; Byrne B; Smith K; Narvaez CJ
J Nutr; 2003 Jul; 133(7 Suppl):2425S-2433S. PubMed ID: 12840219
[TBL] [Abstract][Full Text] [Related]
37. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D and the mammary gland: a review on its role in normal development and breast cancer.
Lopes N; Paredes J; Costa JL; Ylstra B; Schmitt F
Breast Cancer Res; 2012 May; 14(3):211. PubMed ID: 22676419
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.
Pervin S; Hewison M; Braga M; Tran L; Chun R; Karam A; Chaudhuri G; Norris K; Singh R
PLoS One; 2013; 8(1):e53287. PubMed ID: 23341935
[TBL] [Abstract][Full Text] [Related]
40. Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development.
Johnson AL; Zinser GM; Waltz SE
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E674-85. PubMed ID: 25139050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
